Short CommunicationSERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
References (15)
- et al.
Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10
Cytokine
(2000) - et al.
Cloning of the murine interferon-inducible protein 10 (IP-10) receptor and its specific expression in lymphoid organs
Biochem Biophys Res Commun
(1998) - et al.
Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-10 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice
Mol Immunol
(1995) - et al.
Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon γ
J Leukocyte Biol
(1992) - et al.
Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo
Am J Pathol
(1993) - et al.
Expression of IFN-inducible protein-10 in chronic hepatitis
J Immunol
(1997) - et al.
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
J Exp Med
(1998)
There are more references available in the full text version of this article.
Cited by (115)
Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus
2022, International ImmunopharmacologyCitation Excerpt :Our findings were consistent with several previous studies. Some studies revealed that IL-6, IL-10, and IP-10 were highly expressed in SLE patients compared with healthy individuals, and IL-10 was associated with disease activity in SLE patients [19,33,34]. However, Metsariune et al. did not find significant differences in IL-6 concentrations between SLE patients and healthy controls [35].
Elevated serum CXCL10 in patients with Clostridium difficile infection are associated with disease severity
2019, International ImmunopharmacologyChemokines and Cytokines Profiles in Patients with Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: A Preliminary Study
2023, International Journal of Molecular SciencesPrecision medicine in systemic lupus erythematosus
2023, Nature Reviews Rheumatology
- f1
Correspondence to: Shosaku Narumi, Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan. E-mail:[email protected]
Copyright © 2000 Academic Press. All rights reserved.